Clene Closes a $40 Million Public Offering to Further Fund its Efforts Targeting Several Neurodegenerative Diseases
Clene sold 50 million shares of stock, each coupled with two warrants, at a total price of $0.80 per unit. Canacord Genuity served as sole bookrunner on the offering, and after expenses, Clene will receive ~$37.4 million in net proceeds.
Salt Lake City-based Clene (NASDAQ:CLNN) closed a
